Ignition! Three cement enterprises to complete the annual overhaul has resumed production
Release time:
2022-03-11
According to the peak shift production requirements of Yunnan province's industry and information technology, environmental protection and other departments and the arrangement of industry associations, cement enterprises in southwest Yunnan stopped production for
50days in the first quarter. Yunnan peak started its annual overhaul from 2# September 5 , with emphasis on the replacement of 16 m kiln cylinder and the replacement of refractory materials such as decomposition furnace and rotary kiln, the cleaning of the raw material warehouse and the replacement of the breather cloth of the inflatable box involve a wide range, many cross operations and tight construction time. After careful organization and the full cooperation of the participating teams, while successfully completing the established maintenance projects, the phenomenon of running and dripping was comprehensively controlled and rectified. On the afternoon of 3 May 4 , Yunnan Peak successfully completed its annual overhaul and resumed production after ignition. Daye Peak 1
February22 began to overhaul the 2 cement mill. In the following more than a month, the cement mill, kiln system, grate cooler, coal mill, raw mill, packaging hoist and other equipment were successively overhauled and renovated. In order to ensure the quality of maintenance and technical transformation, during this period, Daye Peak strictly implemented the new safety production law, through the advance of the outsourcing team safety disclosure, do a good job in epidemic prevention and control, the implementation of the outsourcing unit operation risk assessment, operation ticket management, safety guardian system, to ensure the safety during maintenance. At the same time, in order to give full play to the work initiative of grass-roots employees, excellent mechanics and post workers are selected to participate in the whole process of overhaul, such as overhaul plan formulation, operation risk assessment, machine material consumption approval, control of key quality nodes, equipment test machine acceptance, etc. The initiative and enthusiasm of employees are significantly improved, and the level of work skills is also improved. 3 August 8 , Daye Peak Rotary Kiln was successfully ignited. This overhaul is the first comprehensive overhaul since Guizhou Huangping Peak was put into production. In order to carry out the maintenance work smoothly, Huang Ping Jianfeng made a thorough maintenance plan in advance, repeatedly reviewing and deliberating the qualification of the construction team entering the factory, the construction plan and schedule, and the procurement of relevant equipment and parts, and the rectification of each system was clearly implemented to the responsible person. In order to enable front-line employees to increase their knowledge and improve their skills from the overhaul, Huang Ping Jianfeng carried out the training on the overhaul site, invited the technicians of relevant manufacturers to provide technical guidance, and arranged the employees of large-scale inspection and other posts to help the outsourcing units and follow the shift to learn, so that the employees learned more knowledge and experience during the overhaul process. On the morning of 3
May9 , Huang Ping Jianfeng finished his first major repair and successfully ignited and resumed production. (Song Xiaofei Wang Yuhua
Huang Xuguang / Wen Liu Feng /)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page